Concepedia

Atsuto Mouri

AM

27

Publications

785

Citations

17

H-Index

2010

Active since

Affiliations

Saitama Medical University(Current)

Saitama International Medical Center

National Hospital Organization

National Disaster Medical Center

Tochigi Cancer Center

Atsuto Mouri is an author at Saitama Medical University specializing in radiation oncology, cancer therapeutics, and lung cancer.

ORCID

Top concepts

Publications per year

2010–2023

27

Publications

27

Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients

Ayako Shiono, Kyoichi Kaira, Atsuto Mouri et al. · Thoracic Cancer · 2019 · 76 citations · Full text

Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer

Kosuke Hashimoto, Kyoichi Kaira, Ou Yamaguchi et al. · Journal of Clinical Medicine · 2020 · 58 citations · Full text

Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto et al. · Thoracic Cancer · 2019 · 51 citations · Full text

Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer

Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi et al. · Cancer Chemotherapy and Pharmacology · 2019 · 50 citations

, , +8

Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non‐small cell lung cancer: Management of adverse events

Yu Miura, Atsuto Mouri, Kyoichi Kaira et al. · Thoracic Cancer · 2020 · 50 citations · Full text

Rows per page

1–5 of 27